The decline in Janux Therapeutics' share price is directly tied to the market's reaction to their Q1 financial results. Typically, financial results can significantly impact a company's stock price, especially if they fall short of market expectations. The immediate negative reaction suggests that the results may have been below investor expectations, leading to a decrease in stock value.